Market Overview

The Africa medical cannabis market size reached USD 1.9 Billion in 2025 and is projected to expand to USD 8.2 Billion by 2034. The market is expected to grow at a CAGR of 17.24% over the forecast period from 2026 to 2034. This growth is driven by the legalization of medical cannabis across Africa, which has accelerated approval processes for THC- and CBD-infused drugs used to treat ailments such as insomnia, inflammation, depression, anxiety, and chronic pain. The increasing popularity of cannabis-infused edible products and the entry of international players into the African production landscape further bolster market growth.

How AI is Reshaping the Future of Africa Medical Cannabis Market

• AI-powered analytics optimize cultivation conditions, enhancing yields and quality of medical cannabis, improving market supply capabilities.

• Machine learning algorithms assist companies in predictive modeling for patient responses to cannabinoid therapies, driving personalized medicine applications.

• AI-enabled regulatory technologies streamline approval processes for THC- and CBD-based products, facilitating faster market entry.

• Integration of AI in supply chain management improves tracking and quality control, enhancing consumer trust and product safety.

• Several companies leverage AI-driven consumer insights and behavior research to tailor medical cannabis products to patient needs.

Grab a sample PDF of this report: https://www.imarcgroup.com/africa-medical-cannabis-market/requestsample

Market Growth Factors

The rapid legalization of medical cannabis across African countries has been a key driver of market growth. With governmental approvals accelerating for THC- and CBD-infused drugs, companies can bring medicinal products to market faster. For example, the acceptance of cannabinoid drugs for treating conditions like insomnia, inflammation, and chronic pain has increased patient access and demand. This regulatory support incentivizes both local and international players to invest and expand production facilities in Africa, benefiting from the continent's favorable conditions and low-cost resources.

Growing awareness of the health benefits of medical cannabis, particularly for cancer patients, plays a significant role in expanding the market. The medical sativa industry in South Africa today is gaining strong momentum as part of this trend. Cannabis products help improve poor appetite, reduce muscle spasms, alleviate pain, and control nausea, which increases their therapeutic use. The rise of cannabis-infused edibles, such as pills, chocolates, brownies, and cookies, appeals to patients seeking prolonged treatment options for psychotic ailments, thereby boosting product adoption and diversity.

International investment in Africa’s medical cannabis sector has further catalyzed growth. Favorable geographic and climatic conditions combined with low labor costs attract major global companies to establish cultivation and processing units. The medical sativa industry in South Africa today continues to attract significant attention due to these advantages. This influx of foreign direct investment enhances local capabilities, production capacities, and export potential, positioning Africa as a significant player in the global medical cannabis market. This trend is complemented by continuous research, development centers, and pharmaceutical collaborations that spur market evolution.

Market Segmentation

Breakup by Species:

• Cannabis Indica
• Sativa
• Hybrid

Breakup by Derivative:

• Cannabidiol
• Tetrahydrocannabinol
• Others

Breakup by Route of Administration:

• Capsules and Oral Solutions
• Vaporizers
• Smoking
• Topicals
• Others

Breakup by Application:

• Cancer
• HIV/AIDS
• Epilepsy
• Pain
• Others

Breakup by End User:

• Pharmaceutical Industry
• Research and Development Centers
• Others

Breakup by Country:

• Lesotho
• Zimbabwe
• South Africa
• Ghana
• Zambia
• Malawi

Recent Development & News

• August 2025: The African government in partnership with educational institutions launched a comprehensive training program on medical cannabis cultivation and regulatory compliance, aiming to enhance the skilled workforce and streamline drug approvals across multiple countries.

• June 2025: Medigrow Africa announced the expansion of its cultivation facilities, increasing output capacity by 30%, which is expected to meet rising demand for cannabis-derived pharmaceuticals in Southern Africa.

• October 2025: Industry reports highlighted a 25% increase in medical cannabis product registrations in key African markets, reflecting heightened consumer acceptance and accessibility driven by regulatory reforms and international investments.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: [email protected],

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302